Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can a market maker short one day and have its sister company short the next?
Or maybe enough bought into the hype. It’s a typical end of day sell off.
Strange day.
No news from company and only update is a shit ton of shorts.
Wonder how this will close with known shorts and covers.
That quarterly really needs to come out!!
At a turtles pace. Big Pharma and even RVVTF, well didn’t that micro cap get FDA fast track approval and got to stage 3 trials in a couple years? Or something like that?
Anyway for BigPharma, they average 10 years or longer and is the norm whether successful or not.
That big short position is interesting.
“Progressing as planned”
2.1M is total for 10-14.
10-13 says 77K shares total
Huge change in shorts
Market Date FINRA
Non-Exempt Volume FINRA
Exempt Volume FINRA
Short Volume FINRA
Total Volume FINRA
Short Volume Ratio
2022-10-14 1,217,622 + 10,538 = 1,228,160 / 2,160,903 = 56.84
2022-10-13 28,376 + 647 = 29,023 / 77,301 = 37.55
Only changes I see in fintel are massive short positions, to the tune of 1.2M share short.
About 10-20X larger than usual
We’ll still be in mice studies by then
Anything that says possibly by 2030 I have no interest in.
So true man !!!! We don’t ask for much, just some facts for a change .
Time for Sunshine to Shine. Show the goods. Show the progress on the IND application. Show the progress on the Phase I Clinical Trial plan. Seems easy to provide an update on all of this unless.........?
So true …. I feel someone on the inside spent some bucks to give the impression of buying interest. Only to watch it fail again . These jokers need to come clean and as you said do a complete 180 if they want to continue to be here.
We all hope SBFM is involved in that
SBFM has to become transparent and begin releasing results, progress,and restoring shareholder confidence with communication.
If that’s not possible, it probably won’t recover.
In other words, SBFM has to do a 180 pivot and become a company that it’s never been before.
I don’t think that will happen unless they do a round of firing and hiring.
Q3 and what happens with NASDAQ are also imperative.
It will very soon. Patience is the key. I sure have that.
"Hitting $1" is meaningless. It has to close with a bid price of $1.
Someone did short this a while back and held and it paid off $300-400K.
They didn’t cover so it showed up as a FTD, paid a penalty and pocketed a ton of cash. Interesting move.
Will be able to tell soon if it was a short cover or something else.
Almost hit $1 today. Perhaps SBFM will top $1 sometime next week. I accumulated a little more yesterday and today knowing SBFM will either make a comeback in the next couple of months or it won't!
Interesting SBFM green day today!
I took a starting position, yesterday. Best of luck to all here.
SBFM...The Pump-N-Dump that keeps on dumping..."shocker"....
It means exactly that... they're not shorting it anymore... why would they close it out? I don't know.
There's no reason to, unless it was some rookie trying to show off to his boss: that's a theory on the other board, but I'm not buying it.
It's closed. Published.
If something doesn’t make sense, ask away. I’m a bit technical.
Somewhere around 10-12 institutional investors have left out of 23 total.
A few have less than 300 shares worth essentially nothing but looks good on paper as an institutional investor in Sunshine.
Those are also part of that 12 with 1 being a 45 share short but with such small position, it doesn’t make much sense to count them.
Factually, an institutional hedge fund shorted about half a hundred shares (not much) and made a killer profit over the months until it closed out somewhere in July or end of August. Under a thousand bucks.
It’s good the short is closed but the reason why is unknown for such a small short but with a huge gain from March-April to July-August.
What does that mean to US? ??
End of August without looking but I believe they had about 45 days to file that they left, which likely was when this nearing or fell below $1.
Without speculation as to why, I sent them an email. I may call them tomorrow too and see if I can get any further details.
I checked all current institutional investors and only Blackstone had a change and left.
To date, only Blackstone and Camille show a profit, and Blackstone was an institutional short position.
What date was this closed ?
Blackstone has closed their short, profited, and closed out their position. Interesting that they decided not to continue holding the short.
Blackstone Alternative Investment Funds - Blackstone Alternative Multi-Strategy Fund Class I closes position in US8677814035 / Sunshine Biopharma Inc
Security US8677814035 / Sunshine Biopharma Inc
Institution Blackstone Alternative Investment Funds - Blackstone Alternative Multi-Strategy Fund Class I
Latest Disclosed Ownership 0 Shares
Latest Disclosed Value $0 Value
I’m with you I use to be a believer now I believe they are scammers. They have never updated on anything and never moved any science on to the next stages. All big lies.
2022 will definitely go down as a bad year for SBFM. Will 2023 be better? I'm holding 3-5 months to find out.
Idk, If I can hold myself to a decent state right now if I talked to him on the phone. Every conversation that we had in the past, I feel was nothing but a complete lie.
If….. If they actually had something solid, they would had not needed the rs, to uplist. And the whole way the uplist went down? Was 100% completely shady. Doing a rs, locking shareholders out from trading , and then not one piece of evidence showing why they deserve to be on nasdaq. Most of the time when you do uplist it is a celebrated moment. Not the shady way they done it . It’s no wonder the SEC has denied them to accelerate. Kudos on the SEC for doing that . I’m just disgusted that I was a strong supporter here, and I know a lot of good people got hurt by these clowns.
SBFM must acknowledge and request the extension.
I’m sure they will, but f#. They went silent and didn’t address a damn thing. Might call tomorrow, only have one simplified question.
Others should call. Maybe they are because many are down tens of thousands. What is worse is many are down into the 100K or more range.
It’s one thing to be scammed, but being scammed while saying our drug is effective against 10 types of Covid and a multitude of cancers?
Mmm, no.
April is the delisting month based on the 180 day rule, but I think we'll find out before that if they make a comeback in the share price. Not sure what they are doing (or not doing) behind the scenes, but think it will be revealed in 3-5 months.
Yeah. It was obviously imperative that this be accelerated, because AEGIS's Executive Vice President Griffin Cassagne sent a demand letter, and Steve Slilaty copied and pasted the exact same thing. Twice!
The SEC's response was no thanks, and we won't review it. Wonder why this was so important? It started shortly after the uplist and failed, and the PPS plummeted to now almost 1/2 a buck.
Might be time to contact Alyssa wall.
Both AEGIS & SBFM requested acceleration and were denied. Interesting, I did not know Steve requested twice, as well as AEGIS. They did not get approval or acceleration.
AEGIS's acceleration request:
https://fintel.io/doc/sec-sunshine-biopharma-inc-1402328-corresp-2022-february-09-19067-6279
Steve Slilaty's acceleration request to the SEC:
https://fintel.io/doc/sec-sunshine-biopharma-inc-1402328-corresp-2022-february-09-19067-2687
Again here:
https://fintel.io/doc/sec-sunshine-biopharma-inc-1402328-corresp-2022-april-07-19119-3528
From 5/10/22:
"Investing in our common stock involves substantial risk. Please read ?Risk Factors? beginning on page 4 of this prospectus and in the documents we incorporate by reference.
Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense."
https://fintel.io/doc/sec-sunshine-biopharma-inc-1402328-s3-2022-may-10-19123-6630
SEC's denial and refusal to review the two Steve Slilaty acceleration requests as well as AEGIS.
United States securities and exchange commission logo
May 18, 2022
Steve Slilaty
Chief Executive Officer
Sunshine Biopharma, Inc
6500 Trans-Canada Highway, 4th Floor
Pointe-Claire, Quebec, Canada H9R 0A5
Re: Sunshine Biopharma, Inc
Registration Statement on Form S-3
Filed May 10, 2022
File No. 333-264830
Dear Dr. Slilaty:
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alyssa Wall at 202-551-8106 with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc: Jeff Cahlon
Link: https://www.sec.gov/Archives/edgar/data/1402328/000000000022005515/filename1.pdf
What’s is the use of a aegis book runner and all this road show if it’s going to end up in this state of pathos within 6 months ? Crazy
Wonder what the left over Aegis roadshow investors if any are doing
That $40M is probably half that. Company has to prepare to delist or worse, bankruptcy. The notice is a week away.
Corporate investors who have to be paid back will be the first to dump everything to get their investment repaid before suing SBFM along with penalties from being non compliant with NASDAQ and unable to convert warrants to $4.25 a share.
That $40M has to be paid back one way or another, and SBFM does that by using dilution and retail share holders.
That PPT they released was to save their ass with a new round of investors and look how well that worked.
Market cap is hovering between $12-14M and falling.
Danger Will Robinson. This scam hasn’t addressed anything and there is no reason to believe it can recover. Shareholder communications is nonexistent, why would anyone loan this company more money when it went from $8 to $0.65 in less then a year and they have released no PR’s, self promoted or paid articles for nearly 2 months now.
Even the market agrees and they have corporate hedgers shorting and registered the short with a 13F because SBFM is a worthless shell and have nothing of value.
Pumpers would be all over this but they aren’t. This scam may be frozen, suspended, investigated and audited.
The claims they made mostly regarding SBFM-PL4 (Covid) probably got them on a watchlist.
Followers
|
760
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
113754
|
Created
|
10/27/08
|
Type
|
Free
|
Moderators |
SUNSHINE BIOPHARMA INC
ANTI CANCER DRUGS
ANTI CORONA VIRUS RESEARCH
SBFM Transfer Agent
Corporate Stock Transfer
3200 Cherry Creek Dr. South
Suite 430
Denver, CO 80209
(303) 282 - 4800 p
(303) 282 - 5800 f
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |